Skip to main content
. 2020 Aug 15;64(Suppl 3):S180–S185. doi: 10.4103/ija.IJA_221_20

Table 3.

Adverse effects between the two groups

Group P (n=35) Group E (n=35) P*
Pain 12 (34.3%) 3 (8.6%) <0.001
Myoclonus 0 25.8% 0.016
Apnoea 29 (82.9%) 10 (28.6%) <0.001
PONV 0 (0.0%) 2 (5.7%) 0.493
Hypotension 31 (88.6%) 2 (5.7%) <0.001
Hypertension 1 4 0.114

*P<0.05 is significant